Pharmacist-driven CGM Use in the Uninsured Population
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 89 |
| Updated: | 3/30/2019 |
| Start Date: | April 26, 2018 |
| End Date: | December 31, 2019 |
A Pharmacist-driven Continuous Glucose Monitoring Program for Advanced Diabetes Management in an Uninsured Population
This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring
(CGM) to patients (purchased through a grant) and (2) systematically record and analyze the
results of the glucose monitoring by the clinical pharmacists at the clinic.
(CGM) to patients (purchased through a grant) and (2) systematically record and analyze the
results of the glucose monitoring by the clinical pharmacists at the clinic.
Inclusion Criteria:
1. adult 18 years of age or older
2. diagnosis of Type 1 or Type 2 diabetes
3. A1c greater than 8%
4. prescribed basal insulin plus either prandial insulin or a glucagon-like peptide-1
(GLP-1) receptor agonist
Exclusion Criteria:
1. pregnant or breast-feeding
2. on dialysis
3. not appropriate for CGM use based on clinical judgment by the investigators
4. patients with limited English proficiency
We found this trial at
1
site
Virginia Commonwealth University Since our founding as a medical school in 1838, Virginia Commonwealth University...
Click here to add this to my saved trials
